Fullard Michelle E, Thibault Dylan P, Hill Andrew, Fox Joellyn, Bhatti Danish E, Burack Michelle A, Dahodwala Nabila, Haberfeld Elizabeth, Kern Drew S, Klepitskava Olga S, Urrea-Mendoza Enrique, Myers Phillip, Nutt Jay, Rafferty Miriam R, Schwalb Jason M, Shulman Lisa M, Willis Allison W
From the Departments of Neurology (M.E.F., D.P.T., A.H., N.D., A.W.W.) and Biostatistics and Epidemiology (D.P.T., A.H., A.W.W.), University of Pennsylvania School of Medicine; Dan Aaron Parkinson's Rehabilitation Center (J.F.), Leonard Davis Institute of Health Economics (A.W.W.), and Center for Clinical Epidemiology and Biostatistics (A.W.W.), University of Pennsylvania, Philadelphia; Department of Neurobiological Sciences (D.E.B.), University of Nebraska Medical Center, Omaha; Department of Neurology (M.A.B.), University of Rochester, NY; Department of Neurology (E.H.), Temple University, Philadelphia, PA; Department of Neurology (D.S.K., O.S.K.), University of Colorado, Aurora; Greenville Health System (E.-U.M.), SC; Parkinson's Disease Foundation Advocate Group (P.M.), Lakeport, CA; Department of Neurology (J.N.), Oregon Health Sciences University, Portland; Center for Education in Health Sciences (M.R.R.), Northwestern University, Evanston, IL; Department of Neurosurgery (J.M.S.), Henry Ford Medical Group, Detroit, MI; Department of Neurology (L.M.S.), University of Maryland School of Medicine, Baltimore.
Neurology. 2017 Sep 12;89(11):1162-1169. doi: 10.1212/WNL.0000000000004355. Epub 2017 Aug 23.
To examine rehabilitation therapy utilization for Parkinson disease (PD).
We identified 174,643 Medicare beneficiaries with a diagnosis of PD in 2007 and followed them through 2009. The main outcome measures were annual receipt of physical therapy (PT), occupational therapy (OT), or speech therapy (ST).
Outpatient rehabilitation fee-for-service use was low. In 2007, only 14.2% of individuals with PD had claims for PT or OT, and 14.6% for ST. Asian Americans were the highest users of PT/OT (18.4%) and ST (18.4%), followed by Caucasians (PT/OT 14.4%, ST 14.8%). African Americans had the lowest utilization (PT/OT 7.8%, ST 8.2%). Using logistic regression models that accounted for repeated measures, we found that African American patients (adjusted odds ratio [AOR] 0.63 for PT/OT, AOR 0.63 for ST) and Hispanic patients (AOR 0.97 for PT/OT, AOR 0.91 for ST) were less likely to have received therapies compared to Caucasian patients. Patients with PD with at least one neurologist visit per year were 43% more likely to have a claim for PT evaluation as compared to patients without neurologist care (AOR 1.43, 1.30-1.48), and this relationship was similar for OT evaluation, PT/OT treatment, and ST. Geographically, Western states had the greatest use of rehabilitation therapies, but provider supply did not correlate with utilization.
This claims-based analysis suggests that rehabilitation therapy utilization among older patients with PD in the United States is lower than reported for countries with comparable health care infrastructure. Neurologist care is associated with rehabilitation therapy use; provider supply is not.
研究帕金森病(PD)患者的康复治疗利用情况。
我们确定了2007年诊断为PD的174,643名医疗保险受益人,并对他们进行了跟踪,直至2009年。主要结局指标为每年接受物理治疗(PT)、职业治疗(OT)或言语治疗(ST)的情况。
门诊康复按服务收费的使用率较低。2007年,仅有14.2%的PD患者有PT或OT的报销记录,14.6%有ST的报销记录。亚裔美国人是PT/OT(18.4%)和ST(18.4%)的最高使用者,其次是白种人(PT/OT 14.4%,ST 14.8%)。非裔美国人的利用率最低(PT/OT 7.8%,ST 8.2%)。使用考虑重复测量的逻辑回归模型,我们发现与白种人患者相比,非裔美国患者(PT/OT的调整比值比[AOR]为0.63,ST为0.63)和西班牙裔患者(PT/OT的AOR为0.97,ST为0.91)接受治疗的可能性较小。每年至少看一次神经科医生的PD患者接受PT评估的报销可能性比未接受神经科治疗的患者高43%(AOR为1.43,1.30 - 1.48),OT评估、PT/OT治疗和ST的情况也是如此。在地理上,西部各州康复治疗的使用率最高,但医疗服务提供者的供应与利用率并无关联。
这项基于报销数据的分析表明,美国老年PD患者的康复治疗利用率低于具有类似医疗保健基础设施国家的报告水平。神经科治疗与康复治疗的使用相关;而医疗服务提供者的供应则无关。